Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical study

Ontario Study Finds 24 Prescribing Cascades

Analysis based on 6 articles · First reported Sep 10, 2026 · Last updated Sep 18, 2026

Sentiment
-5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study could raise awareness among clinicians and patients about unnecessary prescribing, potentially reducing demand for certain follow-on medications and lowering healthcare costs over time. Pharmaceutical companies selling drugs commonly involved in prescribing cascades may face increased scrutiny, though the study does not recommend avoiding any specific medications outright.

pharmaceuticals healthcare

A new Canada — Ontario-wide study published in BMJ (company) and led by Paula Rochon of Sinai Health System in Toronto identified 24 potentially inappropriate prescribing cascades (PIPCs) that are common among older adults. A prescribing cascade occurs when a medication side effect is mistaken for a new health condition, leading to an additional prescription that may be unnecessary. The research team, including collaborators from the United States, Belgium, Italy, Israel and Republic of Ireland, previously developed a list of 65 PIPCs with 12 international experts. Using population-level prescription data from ICES, Canada — Ontario's health data institute, the researchers analyzed how common each initial drug was, how often a second drug followed, and how strong the link was between the two, narrowing the list to the 24 most prevalent and potentially harmful cascades. Examples include NSAIDs leading to blood pressure medication, iron supplements leading to laxatives, statins leading to pain relievers, and cholinesterase inhibitors leading to sleep agents. The study highlights that older adults, particularly mature women, are at higher risk due to multiple chronic conditions and polypharmacy. The authors suggest automated clinical decision support tools and greater integration of pharmacists into prescribing could help flag these cascades. The findings add unnecessary costs to the healthcare system and contribute to drug-related harm at the population level.

90 Paula Rochon led study
85 Paula Rochon published study BMJ (company)
60 Paula Rochon created list
50 ICES provided prescription data Paula Rochon
per
Paula Rochon led the study and is the primary spokesperson, driving the research agenda on potentially inappropriate prescribing cascades.
Importance 95.0 Sentiment 0.0
priv
Sinai Health System is the home institution of lead author Paula Rochon and the research base for the study, gaining reputational visibility for population health research.
Importance 70.0 Sentiment 0.0
loc
Canada — Ontario is the jurisdiction whose older adult population and prescription data formed the basis of the study, highlighting provincial healthcare costs and safety.
Importance 65.0 Sentiment 0.0
priv
BMJ (company) published the study, reinforcing its role as a leading venue for clinical and health services research.
Importance 60.0 Sentiment 0.0
priv
ICES provided the population-level prescription data from Canada — Ontario that enabled the analysis of prescribing cascades.
Importance 50.0 Sentiment 0.0
cnt
Canada is the country where the study was conducted, with potential implications for national prescribing practices.
Importance 30.0 Sentiment 0.0
per
Alexander Chaitoff provided independent expert commentary on the study's implications for medication safety in older adults.
Importance 30.0 Sentiment 0.0
per
Vasily Giannakeas is a Sinai Health System researcher and co-author contributing to the study.
Importance 20.0 Sentiment 0.0
per
Nathan Stall is a Sinai Health System researcher and co-author contributing to the study.
Importance 20.0 Sentiment 0.0
per
Christina Reppas-Rindlisbacher is a geriatrician and co-author contributing to the study.
Importance 20.0 Sentiment 0.0
cnt
The United States contributed researchers to the international collaboration on the study.
Importance 15.0 Sentiment 0.0
cnt
Israel contributed researchers to the international collaboration on the study.
Importance 10.0 Sentiment 0.0
per
Weili Wu is research staff involved in the study.
Importance 10.0 Sentiment 0.0
per
Joyce Li is research staff involved in the study.
Importance 10.0 Sentiment 0.0
per
Lavina Matai worked with ICES on the population-level prescription data used in the study.
Importance 10.0 Sentiment 0.0
+ 4 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.